… effective antiviral therapy for COVID-19 is … antiviral therapies for COVID-19, including
research spanning preclinical and clinical drug development efforts, with an emphasis on antiviral …

… and in vivo antiviral activity against SARS-CoV, MERS-CoV and SARS-CoV-2. Lopinavir/…
, were examined for COVID-19 as they were found to be effective in earlier CoV outbreaks. …

… We simulated antiviral therapies on top of our natural history model to shed light on the
possible impact of the timing and potency of antiviral therapies on outcomes. While accurate …

… coronavirus 2 (SARS-CoV-2) infectious disease (COVID-19) … requirement of suitable antiviral
agent/therapy to control this … of SARS-CoV-2 infection is the crosstalk between the SARS-…

… antiviral drugs as treatment of SARS-CoV-2. This can accelerate the containment of the
SARS-CoV-2 … SARS-CoV-2 is a new human coronavirus identified in patients with acute …

… SARS and MERS, have been used in patients with COVID-19. … of five antivirals applied to
patients with COVID-19, that have … studies or in studies on SARS-CoV and MERS.; An intensive …

… SARS-CoV-2 virus was isolated from the respiratory samples of patients … SARS-CoV-2 virus
was propagated in Vero cells and used in this study. All experiments with SARS-CoV-2 virus …

… identify antivirals to curtail the COVID-19 pandemic. Herein, we report the sensitivity of
SARS-CoV-2 … These results suggest that SARS-CoV-2 is more sensitive than many other human …

… Our study showed that early SARS-CoV-2 antiviral therapy reduces the risk of disease
progression and, consequently, hospitalisation and death. However, prospective studies with a …

… potent inhibitors with SARS-CoV-2 PLpro. In contrast to the identical active sites, there are
differences in amino acids proximal to the BL2 loop between SARS and SARS-CoV-2 PLpro; …